GSA Capital Partners LLP Grows Stock Holdings in Dolby Laboratories $DLB

GSA Capital Partners LLP grew its stake in shares of Dolby Laboratories (NYSE:DLBFree Report) by 312.1% during the 4th quarter, HoldingsChannel.com reports. The fund owned 23,096 shares of the electronics maker’s stock after purchasing an additional 17,492 shares during the quarter. GSA Capital Partners LLP’s holdings in Dolby Laboratories were worth $1,483,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. Boothbay Fund Management LLC increased its holdings in shares of Dolby Laboratories by 4.1% during the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock valued at $299,000 after acquiring an additional 157 shares in the last quarter. Fifth Third Bancorp increased its holdings in shares of Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after acquiring an additional 192 shares in the last quarter. Gabelli Funds LLC increased its holdings in shares of Dolby Laboratories by 0.4% during the third quarter. Gabelli Funds LLC now owns 49,143 shares of the electronics maker’s stock valued at $3,556,000 after acquiring an additional 202 shares in the last quarter. Hantz Financial Services Inc. increased its holdings in shares of Dolby Laboratories by 166.7% during the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock valued at $25,000 after acquiring an additional 220 shares in the last quarter. Finally, Raymond James Financial Inc. increased its holdings in shares of Dolby Laboratories by 1.0% during the second quarter. Raymond James Financial Inc. now owns 24,344 shares of the electronics maker’s stock valued at $1,808,000 after acquiring an additional 235 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on DLB shares. Barrington Research restated an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, April 27th. Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, January 31st. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Friday, March 27th. Finally, Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a report on Friday, January 30th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $90.75.

Check Out Our Latest Research Report on Dolby Laboratories

Insider Buying and Selling

In related news, SVP John D. Couling sold 7,666 shares of the stock in a transaction that occurred on Tuesday, May 5th. The shares were sold at an average price of $57.55, for a total value of $441,178.30. Following the transaction, the senior vice president owned 118,353 shares in the company, valued at approximately $6,811,215.15. This represents a 6.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $54.90, for a total transaction of $164,700.00. Following the sale, the senior vice president directly owned 80,603 shares in the company, valued at $4,425,104.70. The trade was a 3.59% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 20,249 shares of company stock worth $1,157,434. 37.93% of the stock is owned by company insiders.

Dolby Laboratories Trading Up 1.1%

Shares of NYSE:DLB opened at $53.98 on Thursday. Dolby Laboratories has a twelve month low of $52.45 and a twelve month high of $77.00. The company’s 50 day moving average is $60.42 and its 200 day moving average is $63.50. The company has a market cap of $5.11 billion, a PE ratio of 21.34 and a beta of 0.86.

Dolby Laboratories (NYSE:DLBGet Free Report) last issued its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The company had revenue of $395.63 million for the quarter, compared to the consensus estimate of $385.80 million. During the same quarter in the prior year, the company earned $1.34 EPS. Dolby Laboratories’s quarterly revenue was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Equities research analysts predict that Dolby Laboratories will post 3.22 earnings per share for the current fiscal year.

Dolby Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were issued a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 2.7%. The ex-dividend date was Tuesday, May 12th. Dolby Laboratories’s dividend payout ratio is 56.92%.

About Dolby Laboratories

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Read More

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.